 |
|
Illness finder is a diagnostic medicine tool for educational purpose that looks up your patients' health conditions or symptoms and diagnosis and find diseases or illnesses based on chosen gender, age, risk factors, illness, signs, symptoms and prevalence. Illnessfinder is inspired by Evidence based medicine (EMB) and healthcare that aims to apply the best (most reliable) knowledge that is available at decision time. Illnessfinder aims to free up time for the therapeutic dialogue and ensure quality at the evidence based practice, uniting proven medical findings and clinical evidence with systematised data technology.
| Enter a medical term |
| Hemibody Irradiation | Legal notice |
Other terms
Irradiation, Half-Body,Irradiation, Half Body,Sequential Hemibody Irradiation,Hemibody Irradiation, Sequential,Hemibody Irradiations, Sequential,Irradiation, Sequential Hemibody,Irradiations, Sequential Hemibody,Sequential Hemibody Irradiations,Hemi-Body Irradiation,Hemi Body Irradiation,Hemi-Body Irradiations,Irradiation, Hemi-Body,Irradiations, Hemi-Body,Irradiation, Hemibody,Hemibody Irradiations,Irradiations, Hemibody,Half-Body Irradiation,Half Body Irradiation,Half-Body Irradiations,Irradiations, Half-Body,Systemic Hemibody Irradiation,Hemibody Irradiation, Systemic,Hemibody Irradiations, Systemic,Irradiation, Systemic Hemibody,Irradiations, Systemic Hemibody,Systemic Hemibody Irradiations
Description
Hemibody Irradiation: Irradiation of one half or both halves of the body in the treatment of disseminated cancer or widespread metastases. It is used to treat diffuse metastases in one session as opposed to multiple fields over an extended period. The more frequent treatment modalities are upper hemibody irradiation (UHBI) or lower hemibody irradiation (LHBI). Less common is mid-body irradiation (MBI). In the treatment of both halves of the body sequentially, hemibody irradiation permits radiotherapy of the whole body with larger doses of radiation than could be accomplished with WHOLE-BODY IRRADIATION. It is sometimes called "systemic" hemibody irradiation with reference to its use in widespread cancer or metastases. (P. Rubin et al. Cancer, Vol 55, p2210, 1985)
Pervious tree
Next tree
Other locations in tree
Legal notice
The U.S. National Library of Medicine is the creator, maintainer, and provider of the data above.
The version of the data is 2010 MeSH. Last reviewed April 26, 2010. No modification has been made in the content of the file.
Neither the United States Government, nor any of its agencies, contractors, subcontractors or employees makes any warranties, expressed or implied, with respect to data contained in the database, and, furthermore, assumes no legal liability for any party's use, or the results of such use, of any part of the database.
You will not assert any proprietary rights to any portion of the database, or represent the database or any part thereof to anyone as other than a United States Government database.
The MeSH data carry an international copyright outside the United States, its Territories or Possessions. These terms and conditions are in effect as long as the user retains any of the MeSH data obtained from this site.